NPI: 1477515575 · AIKEN, SC 29801 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (SR DIRECTOR LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,574 | $34K |
| 2019 | 7,617 | $21K |
| 2020 | 8,338 | $26K |
| 2021 | 3,406 | $6K |
| 2022 | 2,201 | $19K |
| 2023 | 673 | $9K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 11,462 | 1,179 | $79K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 2,045 | 495 | $22K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 392 | 258 | $6K |
| G0008 | Administration of influenza virus vaccine | 28 | 27 | $4K |
| A4657 | Syringe, with or without needle, each | 1,377 | 891 | $1K |
| J1756 | Injection, iron sucrose, 1 mg | 706 | 224 | $1K |
| 83970 | 922 | 663 | $731.94 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,484 | 669 | $363.53 |
| 82728 | 554 | 441 | $188.72 | |
| 83540 | 581 | 457 | $170.70 | |
| 83550 | 582 | 458 | $169.79 | |
| 85045 | 605 | 527 | $108.51 | |
| 85048 | 892 | 752 | $104.14 | |
| 85041 | 890 | 751 | $103.74 | |
| 90674 | 17 | 16 | $47.60 | |
| 82108 | 60 | 54 | $30.37 | |
| 86706 | 17 | 17 | $16.26 | |
| 87340 | 17 | 17 | $14.91 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 178 | 54 | $0.00 |